Home
>
US Stocks
>
Tarsus Pharmaceuticals Inc
Tarsus Pharmaceuticals Inc
TARS

Tarsus Pharmaceuticals Inc (TARS)

$20.674.31%

  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open$21.61
Today Low/High$20.3 / $21.61
52 Week Low/High$20.08 / $46.62
Market Cap$454.89M

Company Details

Tarsus Pharmaceuticals, Inc. is a late clinical-stage biopharmaceutical company that applies proven science and new technology to revolutionize treatment for patients, starting with eye care. It is advancing its pipeline to address a number of diseases with high unmet need across a range of therapeutic categories, including eye care, dermatology, and infectious disease prevention. Its lead product candidate, TP-03, is a novel therapeutic in Phase 2b/3 for the treatment of Demodex blepharitis. TP-03 is also being developed for the treatment of Meibomian Gland Disease.
OrganisationTarsus Pharmaceuticals Inc
Employees20
IndustryHealth Technology

Discover more

Frequently Asked Questions

What is Tarsus Pharmaceuticals Inc (TARS) share price today?

Can Indians buy Tarsus Pharmaceuticals Inc (TARS) shares?

How can I buy Tarsus Pharmaceuticals Inc (TARS) shares from India?

Can Fractional shares of Tarsus Pharmaceuticals Inc (TARS) be purchased?

What are the documents required to start investing in Tarsus Pharmaceuticals Inc (TARS) stocks?